Peptide-based therapy in lupus: promising data. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Advances in Experimental Medicine and Biology Année : 2007

Peptide-based therapy in lupus: promising data.

Résumé

Systemic lupus erythematosus (SLE) is a multisystem chronic inflammatory disease of multifactorial aetiology, characterized by inflammation and damage of various tissues and organs. Current treatments of the disease are mainly based on immunosuppressive drugs such as corticosteroids and cyclophosphamide. Although these treatments have reduced mortality and morbidity, they cause a non-specific immune suppression. To avoid these side effects, our efforts should focus on the development of alternative therapeutic strategies, which consist, for example in specific T cell targeting using autoantigen-derived peptides identified as sequences encompassing major epitopes.

Domaines

Immunologie
Fichier non déposé

Dates et versions

hal-03713651 , version 1 (04-07-2022)

Identifiants

Citer

Fanny Monneaux Gadroy, Sylviane Muller. Peptide-based therapy in lupus: promising data.. Advances in Experimental Medicine and Biology, 2007, 601, ⟨10.1007/978-0-387-72005-0_11⟩. ⟨hal-03713651⟩

Collections

CNRS SITE-ALSACE
15 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More